SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	65.78	53.41	61.21	62.4	108.25	24
Cash & Short-Term Investments	65.78	53.41	61.21	62.4	108.25	24
Cash Growth	28.58%	-12.75%	-1.90%	-42.36%	351.08%	64.95%
Other Receivables	17.93	13.38	14.43	12.41	14.7	10.67
Receivables	17.93	13.38	14.43	12.41	14.7	10.67
Prepaid Expenses	1.82	4.56	18.37	0.26	17.29	0.25
Other Current Assets	0	-0	-0	-0	-0	0
Total Current Assets	85.53	71.35	94	75.06	140.23	34.92
Property, Plant & Equipment	1.07	1.21	1.94	0.66	2.1	3.18
Long-Term Investments	-	0.04	0.14	0.14	0.27	0.27
Long-Term Deferred Charges	151.14	147.82	154.59	152.16	-	-
Other Long-Term Assets	0.14	0.09	19.85	0	-	-
Total Assets	237.88	220.52	270.52	228.02	142.6	38.37
Accounts Payable	6.56	9.49	17.35	9.67	4.72	4.25
Accrued Expenses	7.55	11.14	10.09	9.82	4.91	7.89
Current Portion of Leases	0.64	0.62	0.6	0.58	1	0.98
Other Current Liabilities	0.17	0.28	0.42	4.88	4.38	2.27
Total Current Liabilities	14.91	21.52	28.46	24.94	15.01	15.39
Long-Term Leases	0.44	0.6	1.29	0.06	1.06	2.11
Long-Term Deferred Tax Liabilities	17.9	17.5	18.3	18.02	-	-
Other Long-Term Liabilities	10.89	10.61	8.3	8.82	-	-
Total Liabilities	44.14	50.23	56.35	51.83	16.08	17.5
Common Stock	7.03	6.67	5.81	4.45	3.71	3.25
Additional Paid-In Capital	881.04	835.34	762.8	646.57	394.84	193.6
Retained Earnings	-709.32	-683.83	-573	-490.6	-274.79	-175.59
Comprehensive Income & Other	15	12.11	18.56	15.77	2.77	-0.4
Shareholders' Equity	193.74	170.29	214.17	176.19	126.52	20.87
Total Liabilities & Equity	237.88	220.52	270.52	228.02	142.6	38.37
Total Debt	1.07	1.21	1.88	0.64	2.06	3.09
Net Cash (Debt)	64.71	52.2	59.33	61.76	106.18	20.91
Net Cash Growth	30.68%	-12.02%	-3.94%	-41.84%	407.85%	43.72%
Net Cash Per Share	1.24	1.02	1.50	1.90	3.85	0.81
Filing Date Shares Outstanding	53.21	53.33	49.01	35.57	31.82	26.01
Total Common Shares Outstanding	53.21	53.33	46.49	35.57	29.65	26.01
Working Capital	70.62	49.82	65.54	50.12	125.22	19.53
Book Value Per Share	3.64	3.19	4.61	4.95	4.27	0.80
Tangible Book Value	193.74	170.29	214.17	176.19	126.52	20.87
Tangible Book Value Per Share	3.64	3.19	4.61	4.95	4.27	0.80